Roland Schmieder - On the Symplicity HTN-3 press release and hypertension treatments

Roland Schmieder (Germany) answers the following questions:

- Please share with us your thoughts on the Symplicity HTN-3 press release
- How has this new information impacted your clinical practice as related to renal denervation?
- What is the vision of ESH on this matter?
- What are the most significant advancements in hypertension treatments in the past 5 years?


To leave a comment, please create your free account here !